|
Doripenem
|
D000077726 |
[A carbapenem derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of infections such as HOSPITAL-ACQUIRED PNEUMONIA, and complicated intra-abdominal or urinary-tract infections, including PYELONEPHRITIS.
] |
|
Desvenlafaxine Succinate
|
D02.033.415.510.500.303 |
|
|
Delftia acidovorans
|
B03.660.075.090.766.170.030 |
|
|
Delftia
|
B03.660.075.090.766.170 |
|
|
Cefepime
|
D000077723 |
[A fourth-generation cephalosporin antibacterial agent that is used in the treatment of infections, including those of the abdomen, urinary tract, respiratory tract, and skin. It is effective against PSEUDOMONAS AERUGINOSA and may also be used in the empiric treatment of FEBRILE NEUTROPENIA.
] |
|
Ertapenem
|
D000077727 |
[A carbapenem derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of Gram-positive and Gram-negative bacterial infections including intra-abdominal infections, acute gynecological infections, complicated urinary tract infections, skin infections, and respiratory tract infections. It is also used to prevent infection in colorectal surgery.
] |
|
Cilastatin, Imipenem Drug Combination
|
D000077728 |
[Combination of imipenem and cilastatin that is used in the treatment of bacterial infections; cilastatin inhibits renal dehydropeptidase I to prolong the half-life and increase the tissue penetration of imipenem, enhancing its efficacy as an anti-bacterial agent.
] |
|
Antineoplastic Protocols
|
E02.183.750 |
|
|
Keratoderma, Palmoplantar, Epidermolytic
|
C17.800.428.435.440.500 |
|
|
Keratoderma, Palmoplantar, Diffuse
|
C17.800.428.435.440 |
|
|
Amniocentesis
|
E05.200.500.384.050 |
|
|
Fidaxomicin
|
D000077732 |
[A narrow-spectrum macrolide antibacterial agent that is used in the treatment of diarrhea associated with CLOSTRIDIUM DIFFICILE INFECTION.
] |
|
Palmitoyl-CoA Hydrolase
|
D08.811.277.352.897.700 |
|
|
Immunoglobulin G4-Related Disease
|
D000077733 |
[A spectrum of systemic autoimmune diseases in which IMMUNOGLOBULIN G4 plays a pathophysiologic role. It can affect multiple organs in highly variable presentations, characterized by inflammatory lesions composed of IgG4-positive PLASMA CELLS, further infiltrated by T helper cells (T-LYMPHOCYTES, HELPER-INDUCER) when linked to progressive FIBROSIS and eventual organ damage.
] |
|
Olfactometry
|
E01.370.376.625 |
|
|
Meropenem
|
D000077731 |
[A thienamycin derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of bacterial infections, including infections in immunocompromised patients.
] |
|
NAV1.2 Voltage-Gated Sodium Channel
|
D12.776.157.530.400.875.750.200 |
|
|
MAP Kinase Kinase 4
|
D12.644.360.440.400 |
|
|
Gatifloxacin
|
D000077734 |
[A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
] |
|
Gemifloxacin
|
D000077735 |
[A naphthyridine and fluoroquinolone derivative antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used for the treatment of community-acquired pneumonia and acute bacterial infections associated with chronic bronchitis.
] |
